Sun Pharma Share Price Target 2025 to 2040

Last updated on December 11th, 2024 at 03:55 pm

Sun Pharmaceutical Industries Limited (Sun Pharma) is among India’s leading pharmaceutical companies. With its current share price at ₹1,782, the company is a prominent player in the healthcare sector, both domestically and globally. Let’s dive into Sun Pharma’s future share price targets and growth potential.

About Sun Pharma

WhatsApp Channel Join Now
Telegram Channel Join Now

Sun Pharma is one of the largest specialty generic pharmaceutical companies globally. Known for its robust portfolio of generics, specialty drugs, and over-the-counter products, it caters to over 100 markets worldwide.

Company Details

  • Founded: 1983
  • Headquarters: Mumbai, India
  • Sector: Pharmaceuticals
  • Global Presence: Over 100 countries
  • Competitors: Dr. Reddy’s, Cipla, Lupin

Promoter Details

Promoter NameHolding (%)
Dilip Shanghvi & Family54.48
Public & Institutional Investors45.52

Sun Pharma Share Price Target 2024

Growth Drivers:

  1. Expansion in specialty drugs and generics.
  2. Focus on innovation and R&D.
  • Minimum Target: ₹1,850
  • Maximum Target: ₹1,950

Sun Pharma Share Price Target 2025

Key Catalysts:

  1. Strong global growth in specialty products.
  2. Rising demand for chronic and lifestyle disease treatments.
  • Minimum Target: ₹2,000
  • Maximum Target: ₹2,150

Sun Pharma Share Price Target 2026 to 2030

YearMinimum Target (₹)Maximum Target (₹)
20262,2002,350
20272,4002,600
20282,6502,850
20292,9003,150
20303,2003,500

Sun Pharma Share Price Target 2035

With advancements in biotechnology and personalized medicine, Sun Pharma is poised for substantial growth by 2035.

  • Minimum Target: ₹4,500
  • Maximum Target: ₹5,000

Sun Pharma Share Price Target 2040

By 2040, Sun Pharma’s investments in innovation, market diversification, and R&D are expected to yield impressive returns.

  • Minimum Target: ₹6,500
  • Maximum Target: ₹7,500
See also  Axis Bank Ltd Share Price Prediction 2024, 2025, 2026 to 2030 in Future Return !

Final Thoughts

Sun Pharma remains a strong contender for long-term investments due to its consistent innovation, robust global presence, and focus on high-demand healthcare segments.

Disclaimer: Always conduct thorough research or consult a financial advisor before investing in stocks. For more insights, visit moneyphobia.in!

I am skilled Us based content writer with 2+ year Experience I creates engaging, well-researched articles on finance, technology, and industry topics.

Leave a Comment